All Stories

  1. Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

    Article • OncoTargets and Therapy, January 2018, Dove Medical Press

    Professor Ahmet Özet

  2. BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report

    Article • Case Reports in Surgery, January 2018, Hindawi Publishing Corporation

    Professor Ahmet Özet, YASAR SUBUTAY PEKER

  3. Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

    Article • OncoTargets and Therapy, December 2014, Taylor & Francis

    Professor Ahmet Özet